These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 6758224

  • 1. A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.
    Dixon KE, Williams RG, Pongsupat T, Pitaktong U, Phintuyothin P.
    Trans R Soc Trop Med Hyg; 1982; 76(5):664-7. PubMed ID: 6758224
    [Abstract] [Full Text] [Related]

  • 2. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM, Phiri DE, Sheth UK, Mukunyandela M.
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [Abstract] [Full Text] [Related]

  • 3. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.
    Hall AP, Doberstyn EB, Karnchanachetanee C, Samransamruajkit S, Laixuthai B, Pearlman EJ, Lampe RM, Miller CF, Phintuyothin P.
    Br Med J; 1977 Jun 25; 1(6077):1626-8. PubMed ID: 326337
    [Abstract] [Full Text] [Related]

  • 4. Fansidar resistant falciparum malaria acquired in South East Asia.
    Black F, Bygbjerg I, Effersøe P, Gomme G, Jepsen S, Jensen GA.
    Trans R Soc Trop Med Hyg; 1981 Jun 25; 75(5):715-6. PubMed ID: 7036431
    [Abstract] [Full Text] [Related]

  • 5. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
    Harinasuta T, Bunnag D, Vanijanond S, Charoenlarp P, Suntharasmai P, Chitamas S, Sheth UK, Wernsdorfer WH.
    Bull World Health Organ; 1987 Jun 25; 65(3):363-7. PubMed ID: 3311439
    [Abstract] [Full Text] [Related]

  • 6. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
    Niklewski G, Landscheidt H, Glasner H.
    Nervenarzt; 1985 Feb 25; 56(2):101-5. PubMed ID: 3885058
    [No Abstract] [Full Text] [Related]

  • 7. [Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
    Randriamanjaka JR, Le Bras J, Charmot G, Coulaud JP.
    Bull Soc Pathol Exot Filiales; 1989 Feb 25; 82(3):381-4. PubMed ID: 2670291
    [Abstract] [Full Text] [Related]

  • 8. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
    Ellis-Pegler RB, Beeching NJ, Eales M, Fraser AG, Wells AU.
    Aust N Z J Med; 1988 Aug 25; 18(5):733-4. PubMed ID: 3072955
    [No Abstract] [Full Text] [Related]

  • 9. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM, Sheth UK, Wernsdorfer WH, Trigg PI, Doberstyn EB.
    Bull World Health Organ; 1987 Aug 25; 65(3):357-61. PubMed ID: 3311438
    [Abstract] [Full Text] [Related]

  • 10. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP, Wetsteyn JC, Meuwissen JH.
    Trop Geogr Med; 1982 Aug 25; 34(3):263-5. PubMed ID: 6758246
    [Abstract] [Full Text] [Related]

  • 11. Falciparum malaria acquired in the area of the Thai-Khmer border resistant to treatment with Fansidar.
    Johnson DE, Roendej P, Williams RG.
    Am J Trop Med Hyg; 1982 Sep 25; 31(5):907-12. PubMed ID: 6751111
    [No Abstract] [Full Text] [Related]

  • 12. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
    De Geus A, Meuwissen JH, van Rijn A.
    Trop Geogr Med; 1982 Sep 25; 34(3):261-3. PubMed ID: 6758245
    [No Abstract] [Full Text] [Related]

  • 13. Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.
    Herzog C, Kibbler CC, Ellis CJ, Mtawali CV.
    Br Med J (Clin Res Ed); 1983 Oct 01; 287(6397):947-8. PubMed ID: 6412900
    [No Abstract] [Full Text] [Related]

  • 14. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C, Eberlé F, Gazin P, Kouka-Bemba D, Gelas H, Jambou R.
    Bull Soc Pathol Exot; 1990 Oct 01; 83(1):61-5. PubMed ID: 2190706
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Sabah, Malaysia.
    Tan HS, Tan PE.
    Ann Acad Med Singap; 1984 Apr 01; 13(2):170-4. PubMed ID: 6388486
    [Abstract] [Full Text] [Related]

  • 16. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
    Tan Heng Soon, Tan Puay Eng.
    Med J Malaysia; 1983 Sep 01; 38(3):217-23. PubMed ID: 6369092
    [No Abstract] [Full Text] [Related]

  • 17. Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
    Arnold K.
    Lancet; 1985 Mar 23; 1(8430):704. PubMed ID: 2858655
    [No Abstract] [Full Text] [Related]

  • 18. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
    de Souza JM, Sheth UK, de Oliveira RM, Roulet H, de Souza SD.
    Bull World Health Organ; 1985 Mar 23; 63(3):603-9. PubMed ID: 3899397
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
    Salako LA, Aderounmu AF, Laoye JO, Makinde JM, Adio RA.
    Ann Trop Med Parasitol; 1988 Aug 23; 82(4):325-30. PubMed ID: 3075441
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A, Salako LA, Laoye AJ, Modupe Makinde J, Aina Adio R.
    Afr J Med Med Sci; 1988 Dec 23; 17(4):195-200. PubMed ID: 2854365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.